Related Experiment Video
Updated: Oct 25, 2025
Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
Published on: December 15, 2023
Viral hepatitis: Milestones, unresolved issues, and future goals
Pietro Torre1, Andrea Aglitti1, Mario Masarone1
1Internal Medicine and Hepatology Unit, Department of Medicine, Surgery and Dentistry, "Scuola Medica Salernitana," University of Salerno, Salerno 84081, Italy.
Insights
This review covers hepatitis A, B, C, D, and E, detailing their transmission, outcomes, and global impact. It highlights differences in viral hepatitis, including chronic infections and zoonotic transmission of hepatitis E.
Area of Science:
- Hepatology
- Virology
- Public Health
Background:
- Viral hepatitis, encompassing hepatitis A, B, C, D, and E, presents a significant global health challenge characterized by liver inflammation.
- Hepatitis B and C viruses (HBV, HCV) are blood-borne pathogens, often leading to chronic hepatitis, cirrhosis, and affecting over 300 million individuals worldwide.
- Hepatitis D virus (HDV) exacerbates HBV infections, while hepatitis A and E viruses (HAV, HEV) are primarily fecal-orally transmitted, with HEV emerging as a zoonosis in developed nations.
Purpose of the Study:
- To provide a comprehensive overview of the current knowledge regarding hepatitis A, B, C, D, and E.
- To delineate the distinct characteristics of each hepatitis virus, including their epidemiology, transmission routes, and clinical outcomes.
- To identify research gaps and discuss future directions in the management and prevention of viral hepatitis.
Main Methods:
- Systematic review of existing literature on viral hepatitis.
- Analysis of epidemiological data, transmission dynamics, and clinical manifestations of hepatitis A, B, C, D, and E.
- Synthesis of current research findings and identification of areas requiring further investigation.
Main Results:
- Hepatitis B and C infections can lead to chronic liver disease and cirrhosis, with a substantial global burden.
- Hepatitis D coinfection with Hepatitis B results in more severe liver disease outcomes.
- Hepatitis A and E typically cause self-limiting illness, but HEV can lead to chronic infection in immunosuppressed individuals.
Conclusions:
- Understanding the diverse nature of viral hepatitis is crucial for targeted public health interventions.
- Further research is needed to address unresolved issues, particularly concerning chronic infections and emerging zoonotic transmissions.
- Future strategies should focus on prevention, early detection, and improved management of all forms of viral hepatitis.
Abstract:
In this review the current overall knowledge on hepatitis A, B, C, D, and E will be discussed. These diseases are all characterized by liver inflammation but have significant differences in distribution, transmission routes, and outcomes. Hepatitis B virus and hepatitis C virus are transmitted by exposure to infected blood, and in addition to acute infection, they can cause chronic hepatitis, which in turn can evolve into cirrhosis. It is estimated that more than 300 million people suffer from chronic hepatitis B or C worldwide. Hepatitis D virus, which is also transmitted by blood, only affects hepatitis B virus infected people, and this dual infection results in worse liver-related outcomes. Hepatitis A and E spread via the fecal-oral route, which corresponds mainly to the ingestion of food or water contaminated with infected stools. However, in developed countries hepatitis E is predominantly a zoonosis. Although hepatitis A virus and hepatitis E virus are usually responsible for a self-limiting hepatitis, a serious, rarely fatal illness is also possible, and in immunosuppressed patients, such as organ transplant recipients, hepatitis E virus infection can become chronic. The description of goals achieved, unresolved issues, and the latest research on this topic may make it possible to speculate on future scenarios in the world of viral hepatitis.
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:26Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
01:29Microorganisms in Medicine and Therapeutics
01:24Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:23Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...